Plasma ANP and cyclic GMP after physical exercise in patients with mitral valve disease and in healthy subjects

Int J Cardiol. 1993 Jul 15;40(3):203-9. doi: 10.1016/0167-5273(93)90002-x.

Abstract

Plasma levels of both atrial natriuretic peptide (ANP) and cyclic GMP are elevated in patients with various heart diseases as compared to healthy subjects. In this study patients with advanced mitral valve disease (Group A) and healthy subjects (Group B) were exposed to symptom-limited upright stepwise physical exercise on a cycle ergometer. Concentrations of ANP and cyclic GMP were measured in plasma at rest (20 min in supine position) or 5 min after physical exercise by specific radioimmunoassays. Here we show that short dynamic exercise caused a significant increase in plasma levels of ANP and cyclic GMP, in both groups. In Group A strong correlation between plasma ANP and cyclic GMP was found at rest (r = 0.91, P < 0.001, n = 11) and after physical exercise (r = 0.85, P < 0.001, n = 11). In contrast, there was no correlation between plasma concentrations of ANP and cyclic GMP in Group B at rest (r = -0.16, P > 0.05, n = 10) or after exercise loading (r = 0.14, P > 0.05, n = 10). Absolute increases in circulating levels of both substances were not found to correlate in either group. These data suggest that exercise-induced elevations in plasma cyclic GMP may be due not only to ANP release but also to an as yet undetermined factor, possibly EDRF/NO.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Atrial Natriuretic Factor / physiology*
  • Cyclic GMP / blood*
  • Female
  • Hemodynamics / physiology
  • Humans
  • Male
  • Middle Aged
  • Mitral Valve Insufficiency / physiopathology*
  • Mitral Valve Stenosis / physiopathology*
  • Nitric Oxide / physiology
  • Reference Values

Substances

  • Nitric Oxide
  • Atrial Natriuretic Factor
  • Cyclic GMP